Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Single-blinded, Randomized, 2-way Crossover, Performance Study of the EyeMirage (Test Device) Relative to Standard of Care (Reference Device) in Patients Undergoing Standard Eye Examinations for Various Conditions

NCT06908967 is registered in ClinicalTrials.gov with Neuroptek Corporation Inc. as lead sponsor.

NCT NCT06908967
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06908967 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Single-blinded, Randomized, 2-way Crossover, Performance Study of the EyeMirage (Test Device) Relative to Standard of Care (Reference Device) in Patients Undergoing Standard Eye Examinations for Various Conditions
Lead sponsor
Neuroptek Corporation Inc.
Phase
Not applicable
Overall status
Completed
Start date
June 13, 2025
Completion date
February 24, 2026
Enrollment
160 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

visual function